Kidney Cancer
Cancer
Kidney Cancer is treated with 18 medications in our database, including Keytruda, Everolimus, Pazopanib, Sunitinib Malate, Temsirolimus, and 13 more. 14 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Merck & Co., Novartis, Pfizer, Recordati, Exelixis and others. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Kidney Cancer treatment below.
What help exists for Kidney Cancer
12
drugs indexed
7
with copay cards
7
with patient assistance
4
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Kidney Cancer
12 totalEVEROLIMUS
Everolimus
ππFOTIVDA
Tivozanib Β· AVEO
ππTorisel
temsirolimus Β· Pfizer
Afinitor,Β Afinitor Disperz
CABOMETYX
cabozantinib Β· Exelixis
ππVOTRIENT
pazopanib hydrochloride
SUNITINIB MALATE
Sunitinib malate Β· Pfizer
ππPazopanib
pazopanib hydrochloride
ππTemsirolimus
Temsirolimus Injection Β· Pfizer
KEYTRUDA
pembrolizumab Β· Merck
ππINLYTA
axitinib Β· Pfizer
ππDactinomycin
DACTINOMYCIN Β· Recordati
π = copay card Β· π = patient assistance program
Prior authorization patterns for Kidney Cancer drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | Yes | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 20 PA rules for Kidney Cancer drugs. View individual drug pages for complete PA detail.
Grants for Kidney Cancer patients
7 total Β· 4 open- open
Afinitor Everolimus Copay Assistance Program
Novartis
Covers: financial assistance
- open
Afinitor Everolimus Copay Assistance Program
Novartis Pharmaceuticals
Covers: financial assistance
- open
Renal cell carcinoma medication copay grant
Covers: financial assistance
- open
PAN Foundation Renal Cell Carcinoma Medication Copay Grant
PAN Foundation
Covers: financial assistance
- unknown
Novartis Patient Assistance Foundation - Zortress (everolimus)
Novartis Patient Assistance Foundation
Covers: financial assistance
- unknown
PAN Foundation Renal cell carcinoma medication copay grant
PAN Foundation
Covers: financial assistance
- unknown
ChemoExperts Patient Assistance for Everolimus (Afinitor)
ChemoExperts
Covers: transportation, financial assistance